Giorgio Frega

11PUBLICATIONS
40CO-AUTHORS
Cancer cell biologyPredictive and prognostic markersTumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Dec 30, 2025
Molecular Alterations and Pathways in Intrahepatic Cholangiocarcinoma: Available Evidence and New Perspectives.

Martina Astore, Laura Fabbri, Andrea Monte

|Jul 25, 2025
Tumor Immune Microenvironment-Associated Prognostic and Mifamurtide-Response Gene Signatures for Localized Osteosarcoma: A Correlative Study of the ISG/OS-2 Trial.

Emanuela Palmerini, Maria Rosaria Sapienza, Stefano A Pileri

|Oct 26, 2024
Tumor Immune Microenvironment in Intrahepatic Cholangiocarcinoma: Regulatory Mechanisms, Functions, and Therapeutic Implications.

Angela Dalia Ricci, Alessandro Rizzo, Annalisa Schirizzi

|May 26, 2023
The Potential Role of Adjuvant Chemoradiotherapy in Patients with Microscopically Positive (R1) Surgical Margins after Resection of Cholangiocarcinoma.

Andrea Palloni, Silvia Bisello, Ilaria Maggio

|Nov 11, 2022
Second-Line Chemotherapy in Elderly Patients with Advanced Biliary Tract Cancer: A Multicenter Real-World Study.

Alessandro Rizzo, Massimiliano Salati, Giorgio Frega

|Jul 25, 2022
Intensive Follow-Up Program and Oncological Outcomes of Biliary Tract Cancer Patients after Curative-Intent Surgery: A Twenty-Year Experience in a Single Tertiary Medical Center.

Alessandro Rizzo, Riccardo Carloni, Giorgio Frega

Pageof 2

Frequent Collaborators

7 joint publications

Alessandro Rizzo

3 joint publications

Andrea Palloni

3 joint publications

Alessandro Di Federico

3 joint publications

Riccardo Carloni